Skip to content
healthcare.dev

Yuflyma

NDC 72606-023, adalimumab-aaty, kit, from CELLTRION USA, Inc..

Product NDC
72606-023
Status
Listed
Labeler
CELLTRION USA, Inc.
Dosage form
KIT
Route
—
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761219
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72606-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
72606-023-04726060023041 KIT in 1 CARTON (72606-023-04) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET
72606-023-07726060023073 KIT in 1 CARTON (72606-023-07) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET

Linked data

RxNorm, label and prices

Use it

Look up 72606-023 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72606-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72606-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.